| Product Code: ETC7486256 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of plasmid DNA manufacturing into Hong Kong in 2024 continued to be dominated by top exporting countries such as the USA, Germany, Austria, China, and South Korea. Despite a high concentration level measured by the HHI, the industry experienced a negative Compound Annual Growth Rate (CAGR) of -2.14% from 2020 to 2024. Additionally, there was a significant decline in growth rate from 2023 to 2024, indicating a challenging year for this sector. These trends suggest a complex market landscape that may require strategic adjustments for stakeholders operating in this space.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Plasmid DNA Manufacturing Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Plasmid DNA Manufacturing Market - Industry Life Cycle |
3.4 Hong Kong Plasmid DNA Manufacturing Market - Porter's Five Forces |
3.5 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.6 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume Share, By Development Phase, 2021 & 2031F |
3.7 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 Hong Kong Plasmid DNA Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for biopharmaceuticals and gene therapy products |
4.2.2 Technological advancements in plasmid DNA manufacturing processes |
4.2.3 Government initiatives and funding supporting biotechnology and life sciences industries in Hong Kong |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance requirements in the biopharmaceutical sector |
4.3.2 Intense competition from established global players in the plasmid DNA manufacturing market |
5 Hong Kong Plasmid DNA Manufacturing Market Trends |
6 Hong Kong Plasmid DNA Manufacturing Market, By Types |
6.1 Hong Kong Plasmid DNA Manufacturing Market, By Grade |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Grade, 2021- 2031F |
6.1.3 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By R&D Grade, 2021- 2031F |
6.1.4 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By GMP Grade, 2021- 2031F |
6.2 Hong Kong Plasmid DNA Manufacturing Market, By Development Phase |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Pre-Clinical Therapeutics, 2021- 2031F |
6.2.3 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Clinical Therapeutics, 2021- 2031F |
6.2.4 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Marketed Therapeutics, 2021- 2031F |
6.3 Hong Kong Plasmid DNA Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By DNA Vaccines, 2021- 2031F |
6.3.3 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Cell & Gene Therapy, 2021- 2031F |
6.3.4 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3.5 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Hong Kong Plasmid DNA Manufacturing Market, By Disease |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.4.3 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Cancer, 2021- 2031F |
6.4.4 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.4.5 Hong Kong Plasmid DNA Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Hong Kong Plasmid DNA Manufacturing Market Import-Export Trade Statistics |
7.1 Hong Kong Plasmid DNA Manufacturing Market Export to Major Countries |
7.2 Hong Kong Plasmid DNA Manufacturing Market Imports from Major Countries |
8 Hong Kong Plasmid DNA Manufacturing Market Key Performance Indicators |
8.1 Research and development investment in innovative manufacturing technologies |
8.2 Number of collaborations and partnerships with biotech companies and research institutions |
8.3 Percentage of revenue derived from new product developments |
8.4 Adoption rate of advanced quality control measures in manufacturing processes |
8.5 Level of market penetration in emerging biopharmaceutical markets |
9 Hong Kong Plasmid DNA Manufacturing Market - Opportunity Assessment |
9.1 Hong Kong Plasmid DNA Manufacturing Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.2 Hong Kong Plasmid DNA Manufacturing Market Opportunity Assessment, By Development Phase, 2021 & 2031F |
9.3 Hong Kong Plasmid DNA Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Hong Kong Plasmid DNA Manufacturing Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 Hong Kong Plasmid DNA Manufacturing Market - Competitive Landscape |
10.1 Hong Kong Plasmid DNA Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Plasmid DNA Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |